Phibro Animal Health | PAHC - 市值

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.34B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	市值	更改		日
Align Technology	USD 12.28B		1.07B	2026-03
ANI Pharmaceuticals	USD 1.75B		24M	2026-03
Aurora Cannabis	CAD 193.82M		133.39M	2026-03
Bristol-Myers Squibb	USD 123.83B		14.02B	2026-03
Canopy Growth	CAD 125.74M		431.39M	2026-07
Corcept Therapeutics	USD 4.32B		654M	2026-03
Eli Lilly	USD 869.02B		146.97B	2026-03
Henry Schein	USD 8.27B		689M	2026-03
Idexx Laboratories	USD 44.63B		9.39B	2026-03
Merck	USD 297.1B		35.84B	2026-03
Nektar Therapeutics	USD 12.82B		11.96B	2026-07
Pacira	USD 915M		149M	2026-03
Phibro Animal Health	USD 1.51B		126M	2025-12
Prestige Brands	USD 2.8B		161M	2026-03
Supernus Pharmaceuticals	USD 2.98B		126M	2026-03
Zoetis	USD 49.71B		5.74B	2026-03